Related Experiment Video
Updated: Jun 13, 2026

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
Increased cell migration and plasticity in Nrf2-deficient cancer cell lines
G Rachakonda1, K R Sekhar, D Jowhar
1Department of Radiation Oncology, Nashville, TN, USA.
Abstract:
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) expression is deregulated in many cancers. Genetic and biochemical approaches coupled with functional assays in cultured cells were used to explore the consequences of Nrf2 repression. Nrf2 suppression by Keap1-directed ubiquitylation or the expression of independent short hairpin RNA (shRNA)/siRNA sequences enhanced cellular levels of reactive oxygen species, Smad-dependent tumor cell motility and growth in soft agar. Loss of Nrf2 was accompanied by concomitant Smad linker region/C-terminus phosphorylation, induction of the E-cadherin transcriptional repressor Slug and suppression of the cell-cell adhesion protein E-cadherin. Ectopic expression of the wildtype but not dominant-negative Nrf2 suppressed the activity of a synthetic transforming growth factor-beta1-responsive CAGA-directed luciferase reporter. shRNA knock-down of Nrf2 enhanced the activity of the synthetic CAGA reporter, as well as the expression of the endogenous Smad target gene plasminogen activator inhibitor-1. Finally, we found that Nrf2/Smad3/Smad4 formed an immunoprecipitable nuclear complex. Thus, loss of Nrf2 increased R-Smad phosphorylation and R-Smad signaling, supporting the hypothesis that loss of Nrf2 in an oncogenic context-dependent manner can enhance cellular plasticity and motility, in part by using transforming growth factor-beta/Smad signaling.
Insights
Loss of Nuclear factor (erythroid-derived 2)-like 2) (Nrf2) enhances cancer cell motility and growth by increasing reactive oxygen species and activating transforming growth factor-beta/Smad signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Nuclear factor (erythroid-derived 2)-like 2) (Nrf2) expression is frequently altered in various cancers.
- The precise role of Nrf2 in cancer progression, particularly its interaction with other signaling pathways, requires further elucidation.
Purpose of the Study:
- To investigate the functional consequences of Nrf2 suppression in cancer cells.
- To explore the molecular mechanisms by which Nrf2 loss influences tumor cell behavior, including motility and growth.
- To determine the interplay between Nrf2 and transforming growth factor-beta (TGF-β)/Smad signaling.
Main Methods:
- Utilized genetic (short hairpin RNA/small interfering RNA) and biochemical approaches to repress Nrf2 expression.
- Performed functional assays, including soft agar growth and cell motility assessments.
- Analyzed Smad signaling components, E-cadherin, Slug expression, and reporter gene activity.
- Investigated the formation of nuclear complexes involving Nrf2 and Smad proteins via immunoprecipitation.
Main Results:
- Nrf2 suppression led to increased reactive oxygen species, enhanced Smad-dependent tumor cell motility, and elevated growth in soft agar.
- Loss of Nrf2 correlated with increased Smad linker region/C-terminus phosphorylation, Slug induction, and decreased E-cadherin expression.
- Nrf2 repressed TGF-β/Smad signaling, as evidenced by suppressed CAGA reporter activity and reduced plasminogen activator inhibitor-1 expression.
- Nrf2, Smad3, and Smad4 formed an immunoprecipitable nuclear complex, indicating a direct interaction.
Conclusions:
- Loss of Nrf2 promotes cancer cell plasticity and motility, partly through the activation of TGF-β/Smad signaling.
- Nrf2 acts as a negative regulator of Smad signaling, impacting key cellular processes relevant to oncogenesis.
- These findings highlight a novel mechanism by which Nrf2 deregulation contributes to cancer progression.
Related Concept Videos
Cell Migration
Cell Migration
Cell Polarization by Rho Proteins
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Chemotaxis and Direction of Cell Migration
Cancer Cell Migration through Invadopodia

